Share: Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study presented at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif
Visit OAC's Medicare Bridge Resource Hub for practical guidance and resources to help you prepare for your pharmacy visit: #Medicare #BridgeProgram #GLP1 #OAC To view or add a comment, sign in Millions Of Older Americans Now Qualify For GLP-1s Under New Medicare Program Reuters (7/1, Prentice, Niasse) reports a Medicare program starting on Wednesday allows millions of people to qualify for GLP-1 medications for just $50 a month, bringing the highly effective drugs to people aged 65 and older at an affordable price. The 18-month CMS trial program will offer for the first time Novo Nordisks Wegovy and Eli Lillys Foundayo and Zepbound as a weight-loss treatment alone. In the past, Medicare was barred from weight-loss coverage and had paid for the drugs only when prescribed for co-conditions like cardiovascular issues and severe fatty liver disease
A.XiangZ.KraincD.NeveR
However, the triple mechanism also creates more complex interactions with alcohol metabolism compared to simpler GLP-1-only medications like semaglutide
The prescription might say, Inject 0.25 mg (10 units) weekly
